CathSAP’s latest update delivers timely, practice relevant advances across interventional cardiology, led by major guideline updates, including the 2025 Acute Coronary Syndromes Guidelines and the 2024 Lower Extremity Peripheral Artery Disease Guidelines. This year’s updates also feature transformative structural heart disease data, including findings from the EARLY TAVR trial, the FDA approval of TAVR for asymptomatic severe aortic stenosis, and key evidence from EVOLVED, TAVR UNLOAD and ALIGN AR. Gain new insights into coronary and structural interventions – including the innovative SESAME technique – and emerging data in right sided valve disease, such as outcomes from the TRAVEL II trial. Plus, opt into the free Collaborative Maintenance Pathway (CMP) to continue your education and support ongoing MOC requirements. Learn more.